Ovelle Pharmaceuticals

Ovelle Pharmaceuticals

Ovelle Pharmaceuticals


Business Description

This year alone, 25% of babies will develop eczema in their first six months, compared to 3% just two generations ago. So what’s going on? Is there something in the water? The short answer is yes. And the uncomfortable truth is, we’re often the ones putting it there. For example, many baby skincare products contain harsh and unnecessary chemicals, in particular MI (preservatives), and sulfates (foamers) in shampoos, bubble baths and wipes. These can strip the skin of its natural oils, leading to problems such as eczema. It’s not just babies who are suffering – many women and men have had skin reactions to facial skincare, which have left skin red and sensitive. Our research teams continua

Products and Services

Manufacture & marketing of therapeuticskincare pharmaceutical products

Geographical Market(s) Served

France, Belgium, Luxembourg, Netherlands, Ireland, Denmark, Greece, Spain, Northern Ireland, Switzerland, Liechtenstein, Poland, Libya, United States of America (USA), Belize, Suriname, Iraq, United Arab Emirates (UAE), Singapore, China, Hong Kong, United Kingdom (UK)


Coes Road Dundalk Co Louth

Contact Details

+353 42 9332304

This website uses cookies to improve our website, provide more personalised services to you and analyse our traffic. To find out more information about our use of cookies please read our Cookie Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.